Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease

Derivatives of 9-phosphorylated acridine as butyrylcholinesterase inhibitors with antioxidant activity and the ability to inhibit β-amyloid self-aggregation: potential therapeutic agents for Alzheimer’s disease

We investigated the inhibitory activities of novel 9-phosphoryl-9,10-dihydroacridines and 9-phosphorylacridines against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and carboxylesterase (CES). We also studied the abilities of the new compounds to interfere with the self-aggregation of...

Full description

Bibliographic Details
Main Authors: Galina F. Makhaeva, Nadezhda V. Kovaleva, Elena V. Rudakova, Natalia P. Boltneva, Sofya V. Lushchekina, Tatiana Yu Astakhova, Elena N. Timokhina, Olga G. Serebryakova, Alexander V. Shchepochkin, Maxim A. Averkov, Irina A. Utepova, Nadezhda S. Demina, Eugene V. Radchenko, Vladimir A. Palyulin, Vladimir P. Fisenko, Sergey O. Bachurin, Oleg N. Chupakhin, Valery N. Charushin, Rudy J. Richardson
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
9-phosphoryl-9,10-dihydroacridines
9-phosphorylacridines
acetylcholinesterase
butyrylcholinesterase
Alzheimer’s disease
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1219980/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1219980/full

Similar Items